SecBot SecBot
SECBOTREPLAY Home › Report › LFWD

LFWD · Lifeward Ltd

Lifeward Ltd. · S-3 filed Apr 27, 2026 at 17:00 ET

At the news

BEARISHIMPACT 8/10

S-3 filed Apr 27, 2026 at 17:00 ET

Lifeward Ltd. filed an S-3 registration statement on April 27, 2026, registering 7,256,474 ordinary shares for resale by selling shareholders Oramed Pharmaceuticals and Creative Value Capital LP. These shares were issued in connection with the strategic acquisition of Oratech that closed on March 25, 2026. The company will not receive any proceeds, and the shares represent approximately 261% of current shares outstanding, creating a massive potential overhang. The company's auditor has expressed substantial doubt about its ability to continue as a going concern.

  • Registration of 7,256,474 ordinary shares for resale by selling shareholders
  • Shares represent ~261% of the 2,778,585 shares outstanding as of April 24, 2026
  • Maximum aggregate offering price of $50,505,059 based on a $6.96 reference price
  • Company will not receive any proceeds from this offering

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access